Funded Tech Companies
Apexian Pharmaceuticals
Looking for the VC firms that backed Apexian Pharmaceuticals? Private investors and Elevate Ventures joined the equity holders in this biopharmaceutical company.
Company Overview
Company Name
Apexian Pharmaceuticals
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
20 N. Meridian Guaranty Bldg. 801
Indianapolis, IN 46204
USA
Indianapolis, IN 46204
USA
Phone
Website
Email Address
Company Background Information
Overview
Apexian Pharmaceuticals is an emerging clinical stage biotechnology company founded on the scientific discoveries of Dr. Mark R. Kelley, whose groundbreaking work on APE1/Ref-1 redox protein signaling at the Indiana University School of Medicine has provided unique insight into this important biological target.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
7/12/2018
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
David Broecker
Chief Medical Officer
Richard Messmann
Chief Operating Officer
Roger Miller
Chief Scientific Officer
Mark Kelley
VP - Operations
Jan Elkins
VP - R & D
James Wikel
VP - Regulatory Affairs
William Current
VP - Regulatory Affairs
Roberta Smithey
Company Investors
- Elevate Ventures (Chris LaMothe)
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a market leader in private equity transaction data.
Additional Resources for Entrepreneurs